Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

CGM devices use a small filament inserted under ... Notably, one of the largest studies of Medicare claims data demonstrated that avoidable complications of diabetes cost the US healthcare system ...

The Dexcom portfolio in the U.S. consists of the Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring ... coverage for glucose biosensors. Both systems require a prescription and are reimbursed by 97 ...

The Dexcom portfolio in the U.S. consists of the Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring Systems ... hypoglycemia and who have insurance coverage for glucose biosensors.

Medtronic plc is a global leader in medical devices. It develops ... insulin delivery with no pumps or needles and continuous glucose monitoring (“CGM”), impacted sales.

The FDA has approved Eversense 365, a new continuous glucose monitor (CGM) from Senseonics ... Most insurance companies, as well as Medicare, cover the cost of Eversense insertion and removal ...

There was a tiny pin prick when I activated the device ... coverage for glucose biosensors. Both systems require a prescription and are reimbursed by 97% of commercial insurers in the U.S ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

The system’s tubeless pump automatically adjusts insulin levels based on data from a continuous glucose monitor (CGM), replacing manual dosing ... partnerships with other device makers and how the ...